1. Home
  2. MPLT vs WINA Comparison

MPLT vs WINA Comparison

Compare MPLT & WINA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$28.57

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Winmark Corporation

WINA

Winmark Corporation

HOLD

Current Price

$363.28

Market Cap

1.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPLT
WINA
Founded
2018
1988
Country
United States
United States
Employees
133
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
MPLT
WINA
Price
$28.57
$363.28
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$32.67
N/A
AVG Volume (30 Days)
253.4K
32.6K
Earning Date
05-28-2026
04-15-2026
Dividend Yield
N/A
3.76%
EPS Growth
N/A
3.76
EPS
N/A
2.50
Revenue
N/A
$86,055,700.00
Revenue This Year
N/A
$5.55
Revenue Next Year
N/A
$6.03
P/E Ratio
N/A
$145.28
Revenue Growth
N/A
5.86
52 Week Low
$12.24
$338.18
52 Week High
$33.28
$526.81

Technical Indicators

Market Signals
Indicator
MPLT
WINA
Relative Strength Index (RSI) 52.37 43.25
Support Level $26.70 $358.01
Resistance Level $32.23 $483.43
Average True Range (ATR) 2.34 13.11
MACD -0.40 1.85
Stochastic Oscillator 58.24 61.47

Price Performance

Historical Comparison
MPLT
WINA

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

About WINA Winmark Corporation

Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment, including Franchising, and one non-reportable segment, Leasing. The franchising segment franchises value-oriented retail stores that buy, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes the middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.

Share on Social Networks: